Global Joint Disease Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: G896A20EACBEEN
QYResearch

Abstracts

This report focuses on the global Joint Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Joint Disease Therapeutics development in North America, Europe and Asia-Pacific.

The key players covered in this study

• AbbVie
• Pfizer
• Bristol-Myers Squibb
• Roche
• GlaxoSmithKline
• AstraZeneca
• Astellas Pharma
• Johnson&Johnson
• Amgen
• Novartis
• Sanofi
• Daiiachi Sankyo

Market segment by Type, the product can be split into

• Drug Therapy
• Rehabilitation
• Surgical Operation

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Joint Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Joint Disease Therapeutics development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Joint Disease Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Joint Disease Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Joint Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Therapy
  1.4.3 Rehabilitation
  1.4.4 Surgical Operation
1.5 Market by Application
  1.5.1 Global Joint Disease Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Joint Disease Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Joint Disease Therapeutics Industry
    1.6.1.1 Joint Disease Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Joint Disease Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Joint Disease Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Joint Disease Therapeutics Market Perspective (2015-2026)
2.2 Joint Disease Therapeutics Growth Trends by Regions
  2.2.1 Joint Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Joint Disease Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Joint Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Joint Disease Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Joint Disease Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Joint Disease Therapeutics Players by Market Size
  3.1.1 Global Top Joint Disease Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Joint Disease Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Joint Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Joint Disease Therapeutics Market Concentration Ratio
  3.2.1 Global Joint Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Joint Disease Therapeutics Revenue in 2019
3.3 Joint Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Joint Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Joint Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Joint Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Joint Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 JOINT DISEASE THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Joint Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Joint Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Joint Disease Therapeutics Market Size (2015-2020)
6.2 Joint Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Joint Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Joint Disease Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Joint Disease Therapeutics Market Size (2015-2020)
7.2 Joint Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Joint Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Joint Disease Therapeutics Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Joint Disease Therapeutics Market Size (2015-2020)
8.2 Joint Disease Therapeutics Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Joint Disease Therapeutics Market Size by Type (2015-2020)
8.4 Asia-Pacific Joint Disease Therapeutics Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 AbbVie
  9.1.1 AbbVie Company Details
  9.1.2 AbbVie Business Overview and Its Total Revenue
  9.1.3 AbbVie Joint Disease Therapeutics Introduction
  9.1.4 AbbVie Revenue in Joint Disease Therapeutics Business (2015-2020))
  9.1.5 AbbVie Recent Development
9.2 Pfizer
  9.2.1 Pfizer Company Details
  9.2.2 Pfizer Business Overview and Its Total Revenue
  9.2.3 Pfizer Joint Disease Therapeutics Introduction
  9.2.4 Pfizer Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.2.5 Pfizer Recent Development
9.3 Bristol-Myers Squibb
  9.3.1 Bristol-Myers Squibb Company Details
  9.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  9.3.3 Bristol-Myers Squibb Joint Disease Therapeutics Introduction
  9.3.4 Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.3.5 Bristol-Myers Squibb Recent Development
9.4 Roche
  9.4.1 Roche Company Details
  9.4.2 Roche Business Overview and Its Total Revenue
  9.4.3 Roche Joint Disease Therapeutics Introduction
  9.4.4 Roche Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.4.5 Roche Recent Development
9.5 GlaxoSmithKline
  9.5.1 GlaxoSmithKline Company Details
  9.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.5.3 GlaxoSmithKline Joint Disease Therapeutics Introduction
  9.5.4 GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.5.5 GlaxoSmithKline Recent Development
9.6 AstraZeneca
  9.6.1 AstraZeneca Company Details
  9.6.2 AstraZeneca Business Overview and Its Total Revenue
  9.6.3 AstraZeneca Joint Disease Therapeutics Introduction
  9.6.4 AstraZeneca Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.6.5 AstraZeneca Recent Development
9.7 Astellas Pharma
  9.7.1 Astellas Pharma Company Details
  9.7.2 Astellas Pharma Business Overview and Its Total Revenue
  9.7.3 Astellas Pharma Joint Disease Therapeutics Introduction
  9.7.4 Astellas Pharma Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.7.5 Astellas Pharma Recent Development
9.8 Johnson&Johnson
  9.8.1 Johnson&Johnson Company Details
  9.8.2 Johnson&Johnson Business Overview and Its Total Revenue
  9.8.3 Johnson&Johnson Joint Disease Therapeutics Introduction
  9.8.4 Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.8.5 Johnson&Johnson Recent Development
9.9 Amgen
  9.9.1 Amgen Company Details
  9.9.2 Amgen Business Overview and Its Total Revenue
  9.9.3 Amgen Joint Disease Therapeutics Introduction
  9.9.4 Amgen Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.9.5 Amgen Recent Development
9.10 Novartis
  9.10.1 Novartis Company Details
  9.10.2 Novartis Business Overview and Its Total Revenue
  9.10.3 Novartis Joint Disease Therapeutics Introduction
  9.10.4 Novartis Revenue in Joint Disease Therapeutics Business (2015-2020)
  9.10.5 Novartis Recent Development
9.11 Sanofi
  10.11.1 Sanofi Company Details
  10.11.2 Sanofi Business Overview and Its Total Revenue
  10.11.3 Sanofi Joint Disease Therapeutics Introduction
  10.11.4 Sanofi Revenue in Joint Disease Therapeutics Business (2015-2020)
  10.11.5 Sanofi Recent Development
9.12 Daiiachi Sankyo
  10.12.1 Daiiachi Sankyo Company Details
  10.12.2 Daiiachi Sankyo Business Overview and Its Total Revenue
  10.12.3 Daiiachi Sankyo Joint Disease Therapeutics Introduction
  10.12.4 Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2015-2020)
  10.12.5 Daiiachi Sankyo Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Joint Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Joint Disease Therapeutics Revenue
Table 3. Ranking of Global Top Joint Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Joint Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Therapy
Table 6. Key Players of Rehabilitation
Table 7. Key Players of Surgical Operation
Table 8. COVID-19 Impact Global Market: (Four Joint Disease Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Joint Disease Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Joint Disease Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Joint Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Joint Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Joint Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Joint Disease Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Joint Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Joint Disease Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Joint Disease Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Joint Disease Therapeutics Players
Table 24. Global Joint Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Joint Disease Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Joint Disease Therapeutics as of 2019)
Table 27. Global Joint Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Joint Disease Therapeutics Product Solution and Service
Table 30. Date of Enter into Joint Disease Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Joint Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Joint Disease Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Joint Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Joint Disease Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Joint Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Joint Disease Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Joint Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Joint Disease Therapeutics Market Share (2019-2020)
Table 40. North America Joint Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Joint Disease Therapeutics Market Share by Type (2015-2020)
Table 42. North America Joint Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Joint Disease Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Joint Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Joint Disease Therapeutics Market Share (2019-2020)
Table 46. Europe Joint Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Joint Disease Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Joint Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Joint Disease Therapeutics Market Share by Application (2015-2020)
Table 50. Asia-Pacific Key Players Joint Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Asia-Pacific Key Players Joint Disease Therapeutics Market Share (2019-2020)
Table 52. Asia-Pacific Joint Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Asia-Pacific Joint Disease Therapeutics Market Share by Type (2015-2020)
Table 54. Asia-Pacific Joint Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Asia-Pacific Joint Disease Therapeutics Market Share by Application (2015-2020)
Table 56. AbbVie Company Details
Table 57. AbbVie Business Overview
Table 58. AbbVie Product
Table 59. AbbVie Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 60. AbbVie Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Product
Table 64. Pfizer Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 65. Pfizer Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Product
Table 69. Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Product
Table 74. Roche Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 75. Roche Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 80. GlaxoSmithKline Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Product
Table 84. AstraZeneca Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 85. AstraZeneca Recent Development
Table 86. Astellas Pharma Company Details
Table 87. Astellas Pharma Business Overview
Table 88. Astellas Pharma Product
Table 89. Astellas Pharma Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 90. Astellas Pharma Recent Development
Table 91. Johnson&Johnson Business Overview
Table 92. Johnson&Johnson Product
Table 93. Johnson&Johnson Company Details
Table 94. Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 95. Johnson&Johnson Recent Development
Table 96. Amgen Company Details
Table 97. Amgen Business Overview
Table 98. Amgen Product
Table 99. Amgen Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 100. Amgen Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Product
Table 104. Novartis Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 105. Novartis Recent Development
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Product
Table 109. Sanofi Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 110. Sanofi Recent Development
Table 111. Daiiachi Sankyo Company Details
Table 112. Daiiachi Sankyo Business Overview
Table 113. Daiiachi Sankyo Product
Table 114. Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2015-2020) (Million US$)
Table 115. Daiiachi Sankyo Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Joint Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Drug Therapy Features
Figure 3. Rehabilitation Features
Figure 4. Surgical Operation Features
Figure 5. Global Joint Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Joint Disease Therapeutics Report Years Considered
Figure 10. Global Joint Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Joint Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Joint Disease Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Joint Disease Therapeutics Market Share by Players in 2019
Figure 15. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Joint Disease Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Joint Disease Therapeutics Revenue in 2019
Figure 17. North America Joint Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Joint Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Joint Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. AbbVie Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 22. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Pfizer Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 24. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bristol-Myers Squibb Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 26. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 30. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AstraZeneca Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 32. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Astellas Pharma Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 34. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Johnson&Johnson Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 36. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Amgen Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 38. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Novartis Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 42. Daiiachi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Daiiachi Sankyo Revenue Growth Rate in Joint Disease Therapeutics Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed